Meixi Wang

525 total citations
30 papers, 305 citations indexed

About

Meixi Wang is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Meixi Wang has authored 30 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Meixi Wang's work include Liver Disease Diagnosis and Treatment (4 papers), Model Reduction and Neural Networks (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Meixi Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Model Reduction and Neural Networks (3 papers) and Eicosanoids and Hypertension Pharmacology (2 papers). Meixi Wang collaborates with scholars based in China, Saudi Arabia and South Korea. Meixi Wang's co-authors include Xuyang Lou, Zong‐Gen Peng, Baotong Cui, Bo Yang, Zhishui Chen, Chen Dai, Lai Wei, Wei Wu, Duan Wu and Hu Li and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Pharmacology & Therapeutics.

In The Last Decade

Meixi Wang

30 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meixi Wang China 11 132 80 55 34 30 30 305
Amr El-Karef Egypt 11 111 0.8× 95 1.2× 28 0.5× 47 1.4× 59 2.0× 19 368
Xiaoxiao Du China 9 148 1.1× 58 0.7× 50 0.9× 47 1.4× 39 1.3× 15 300
Mi‐Gyeong Gwon South Korea 15 149 1.1× 55 0.7× 36 0.7× 37 1.1× 28 0.9× 27 586
Ting Xiong China 11 171 1.3× 62 0.8× 75 1.4× 48 1.4× 19 0.6× 28 359
Han Guo China 12 181 1.4× 103 1.3× 90 1.6× 65 1.9× 40 1.3× 23 486
Deniz Tümen Germany 7 158 1.2× 47 0.6× 48 0.9× 24 0.7× 43 1.4× 14 306
Ji‐Chao Zhou China 8 178 1.3× 135 1.7× 33 0.6× 34 1.0× 65 2.2× 15 381
Siyi Jin China 11 262 2.0× 119 1.5× 72 1.3× 54 1.6× 67 2.2× 15 464
Shi Zhou China 13 153 1.2× 47 0.6× 107 1.9× 41 1.2× 31 1.0× 38 396

Countries citing papers authored by Meixi Wang

Since Specialization
Citations

This map shows the geographic impact of Meixi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meixi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meixi Wang more than expected).

Fields of papers citing papers by Meixi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meixi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meixi Wang. The network helps show where Meixi Wang may publish in the future.

Co-authorship network of co-authors of Meixi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Meixi Wang. A scholar is included among the top collaborators of Meixi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meixi Wang. Meixi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Meixi, et al.. (2024). The EGR1/miR-139/NRF2 axis orchestrates radiosensitivity of non-small-cell lung cancer via ferroptosis. Cancer Letters. 595. 217000–217000. 19 indexed citations
2.
Wang, Meixi, et al.. (2024). Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease. Renal Failure. 46(1). 2313182–2313182. 3 indexed citations
3.
Wang, Chaonan, Fang Wang, Zhigang Jiang, et al.. (2024). Development and application of one-step multiplex Real-Time PCR for detection of three main pathogens associated with bovine neonatal diarrhea. Frontiers in Cellular and Infection Microbiology. 14. 1367385–1367385. 1 indexed citations
4.
Wang, Meixi, Chaonan Wang, Jun Wang, et al.. (2024). A CRISPR/Cas12a-based platform for rapid on-site bovine viral diarrhea virus diagnostics. Journal of Integrative Agriculture. 23(8). 2872–2876. 2 indexed citations
5.
Wang, Meixi, Xuyang Lou, & Baotong Cui. (2023). Learning-based robust model predictive control with data-driven Koopman operators. International Journal of Machine Learning and Cybernetics. 14(9). 3295–3321. 6 indexed citations
6.
Wang, Meixi & Zong‐Gen Peng. (2023). 17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease. Pharmacology & Therapeutics. 246. 108428–108428. 14 indexed citations
7.
Wang, Xian, et al.. (2023). Clinical significance of Interleukin 17 receptor E in diabetic nephropathy. International Immunopharmacology. 120. 110324–110324. 6 indexed citations
8.
Wang, Meixi, Panpan Ruan, Guangchen Zhang, et al.. (2022). Emodin-induced hepatotoxicity is enhanced by 3-methylcholanthrene through activating aryl hydrocarbon receptor and inducing CYP1A1 in vitro and in vivo. Chemico-Biological Interactions. 365. 110089–110089. 10 indexed citations
9.
Huang, Yifeng, et al.. (2022). Multifaceted roles of zinc finger proteins in regulating various agronomic traits in rice. Frontiers in Plant Science. 13. 974396–974396. 13 indexed citations
10.
Li, Hu, Nannan Liu, Jianrui Li, et al.. (2022). Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6/STAT3 signaling pathway. Biomedicine & Pharmacotherapy. 150. 113083–113083. 13 indexed citations
11.
Li, Hu, Nannan Liu, Jianrui Li, et al.. (2022). Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology. 13. 843872–843872. 16 indexed citations
12.
Li, Xiang, Siyuan Qin, Peng Peng, et al.. (2022). Highly Pathogenic Avian Influenza A(H5Nx) Virus of Clade 2.3.4.4b Emerging in Tibet, China, 2021. Microbiology Spectrum. 10(3). e0064322–e0064322. 9 indexed citations
13.
Zhao, Yuanyuan, Bo Yang, Dong Chen, et al.. (2021). Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma. Aging. 13(3). 4696–4712. 8 indexed citations
14.
Yang, Bo, Duan Wu, Lai Wei, et al.. (2020). Bone Marrow Mesenchymal Stem Cell-Derived Hepatocyte-Like Cell Exosomes Reduce Hepatic Ischemia/Reperfusion Injury by Enhancing Autophagy. Stem Cells and Development. 29(6). 372–379. 43 indexed citations
15.
Wang, Meixi, Yuanyuan Zhao, Lai Wei, et al.. (2020). Immunology of Transplant Patients with SARS-CoV-2 Infection: Transmission, Immune Response, and Therapeutic Strategy. Critical Reviews in Immunology. 40(6). 475–484. 1 indexed citations
16.
Wang, Meixi, et al.. (2020). MRWMDA: A novel framework to infer miRNA-disease associations. Biosystems. 199. 104292–104292. 6 indexed citations
17.
Wang, Meixi, Dong Chen, Yuanyuan Zhao, et al.. (2020). Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation. Hepatobiliary & pancreatic diseases international. 19(4). 378–383. 4 indexed citations
18.
Yang, Bo, Bo Zhang, Chen Dai, et al.. (2018). Autophagy and Akt in the protective effect of erythropoietin helix B surface peptide against hepatic ischaemia/reperfusion injury in mice. Scientific Reports. 8(1). 14703–14703. 24 indexed citations
19.
Wang, Meixi, Hong-Ling Tan, Yuguang Wang, et al.. (2017). [Effect of clinical doses of Realgar-Indigo Naturalis formula and large-dose of realgar on CYP450s of rat liver].. PubMed. 42(3). 593–599. 2 indexed citations
20.
Wang, Meixi. (2010). The Influence of Losartan on ACE2-Ang(1-7)-MAS-ERK Pathway of Hearts in Spontaneously Hypertensive Rats. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amr El-Karef Breakdown of academic impact, for papers by Xiaoxiao Du Breakdown of academic impact, for papers by Mi‐Gyeong Gwon Breakdown of academic impact, for papers by Ting Xiong Breakdown of academic impact, for papers by Han Guo Breakdown of academic impact, for papers by Deniz Tümen Breakdown of academic impact, for papers by Ji‐Chao Zhou Breakdown of academic impact, for papers by Siyi Jin Breakdown of academic impact, for papers by Shi Zhou
Rankless by CCL
2026